Latest Automation News

Knosys Limited is reshaping its future by focusing on its Libero library management platform, aiming to become a global leader through strategic simplification, AI innovation, and geographic expansion.

Gentrack Group has committed an additional AUD4.5 million to Amber’s AUD45 million funding round, reinforcing their strategic partnership to accelerate the global rollout of smart energy technologies.

ikeGPS Group Limited (IKE) reported a robust FY25 with 19% revenue growth driven by subscription gains and improved margins, setting the stage for EBITDA break-even in FY26 H2 amid strong North American market demand.

ikeGPS Group Limited reported a robust 48% growth in annual subscription revenue exit run rate for FY25, alongside improved margins and a narrowed EBITDA loss. Despite a lucrative NZ$1 per share acquisition approach, the company declined the offer, confident in its growth trajectory.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

Goodman Group reports steady progress in Q3 FY25 with a robust $13.7 billion development pipeline and strong demand for logistics and data centre infrastructure, reaffirming its FY25 Operating EPS growth forecast of 9%.

Aspen Group has launched a $4 million Security Purchase Plan (SPP) at $2.90 per security, offering eligible investors a chance to buy new stapled securities without brokerage fees. This move follows a recent $70 million institutional placement aimed at strengthening the balance sheet for future acquisitions.

Talius has deepened its partnership with Silverchain Group to pilot an AI voice assistant aimed at transforming home aged care services, starting with appointment scheduling in Western Australia and eyeing a national rollout.

PainChek Limited has secured a pivotal reseller and integration deal with Eldermark Software, positioning its AI-driven pain assessment app for a major US market rollout pending FDA approval.

ALS Limited has announced a fully underwritten A$350 million equity placement to fund major upgrades to its global laboratory network and support future growth initiatives, aiming for mid single-digit EPS accretion by FY25 pro forma.

ALS Limited delivered a robust FY25 performance with 16% revenue growth to $3 billion and underlying EBIT rising 4.7% to $515 million, driven by strong organic growth and strategic acquisitions. The company is advancing its Nuvisan integration ahead of schedule and has unveiled a $230 million investment plan to expand key laboratories, positioning itself for sustained growth amid market uncertainties.

Veris Limited has secured over $2 million in new digital project contracts, reinforcing its leadership in spatial data consulting across energy, transport, and government sectors. These wins highlight the company’s innovative use of proprietary platforms and advanced data capture technologies.